Category: Avandia



FDA AVANDIA Hearing – Day Two

07/14/10

Wednesday, July 14th, 2010 Today officials meet again in Gaithersburg, Maryland to discuss the fate of the diabetes drug Avandia. FDA decision-makers are given instructions to answer multiple-choice questions that start with the following: Please select the following: A. Avandia (Rosiglitazone) should continue on the market and the black box warning should be removed. B…. read more


FDA AVANDIA Hearing – Day Two update

07/14/10

The officials voting today were presented with multiple choice questions. Question three had a choice of A. The data provides sufficient evidence to raise significant safety concerns in diabetes type 2 patients taking Rosiglitazone (Avandia). B. The data does not provide sufficient evidence to raise significant safety concerns in diabetes type 2 patients taking Avandia…. read more


FDA AVANDIA Hearing

07/13/10

Today, July 13th, 2010, the FDA is currently hosting a hearing regarding the dangerous drug Avandia. Please see our links in MEDIA to view recent news clips from CNN. As Albuquerque personal injury attorneys, we believe Avandia is harmful and consequently should be removed from the market. If you or a loved one has taken… read more



AVANDIA RECENT NEWS

Please see our Avandia information page to learn about the most up-to-date news on the harmful diabetes drug. The attorneys and lawyers at the Branch Law Firm can help you take action against the pharmaceutical giant Glaxo Smith Kline, makers of the diabetes drug Avandia; also known as Rosiglitazone.


NEW MEXICO DANGEROUS DRUGS – AVANDIA RESEARCHERS TIED TO CONFLICTS OF INTERESTS

According to Bloomberg News, 94% of researchers who found positive results from using Avandia had financial ties to pharmaceutical companies. Avandia is a controversial diabetes drug that has been linked to increased sharp increased risk of heart attack and death. Despite the FDA’s issuance of a formal safety alert concerning the risks associated with Avandia,… read more


New Mexico Dangerous Drugs – GlaxoSmithKline Has Duty To Warn Of Avandia Risks

The U.S. Senate Finance Committee has recently issued a report on Avandia, a controversial drug produced by GlaxoSmithKline (“GSK”) to control diabetes. According to the report, GSK knew of possible heart attack risks tied to Avandia many years before the information became public. The report unequivocally states “GSK had a duty to sufficiently warn patients… read more


Harvard Study Links Avandia To Increased Risk of Heart Attack

A soon-to-be-published report by the American Diabetes Association has found that the number of heart attacks by diabetic patients who took Avandia is double that of those who took a different oral diabetic medication. In the study, Harvard University researchers analyzed clinical data from more than 26,375 patients from 2000 to 2006 in the Boston… read more


ttd_dom_ready( function() { if (typeof TTDUniversalPixelApi === 'function') { var universalPixelApi = new TTDUniversalPixelApi(); universalPixelApi.init("jmmb5ng", ["l7u8fw9"], "https://insight.adsrvr.org/track/up"); } });